共 229 条
[41]
Cukierman-Yaffe T(2011)The pharmacologic basis for clinical differences among GLP-1 receptor agonists and DPP-4 inhibitors Postgrad Med 123 189-undefined
[42]
Bosch J(2017)Linagliptin, a dipeptidyl peptidase-4 inhibitor, mitigates cognitive deficits and pathology in the 3xTg-AD mouse model of Alzheimer’s disease Mol Neurobiol 54 6074-undefined
[43]
Diaz R(2016)Insulin resistance and Parkinson's disease: a new target for disease modification? Prog Neurobiol 145-146 98-undefined
[44]
Dyal L(2019)Disease severity and minimal clinically important differences in clinical outcome assessments for Alzheimer’s disease clinical trials Alzheimers Dement (N Y) 5 354-undefined
[45]
Hancu N(2019)Association of metformin, sulfonylurea and insulin use with brain structure and function and risk of dementia and Alzheimer’s disease: pooled analysis from 5 cohorts PLoS One 14 e0212293-undefined
[46]
Hildebrandt P(undefined)undefined undefined undefined undefined-undefined
[47]
Wium-Andersen IK(undefined)undefined undefined undefined undefined-undefined
[48]
Osler M(undefined)undefined undefined undefined undefined-undefined
[49]
Jorgensen MB(undefined)undefined undefined undefined undefined-undefined
[50]
Rungby J(undefined)undefined undefined undefined undefined-undefined